From: Redox Imbalance in Lung Cancer of Patients with Underlying Chronic Respiratory Conditions
Identified carbonylated protein | Accession no. | Mass | MASCOT score |
---|---|---|---|
Lung tumor lesions | |||
α-Enolase, LC-COPD and LC | ENOA_HUMAN | 47.48 | 163 |
Protein DJ-1, LC-COPD and LC | PARK7_HUMAN | 19.9 | 384 |
α2-Macroglobulin, LC-COPD and LC | A2MG_HUMAN | 163.2 | 99 |
Electron transfer flavoprotein subunit alpha, mitochondrial, LC-COPD | ETFA_HUMAN | 35.1 | 490 |
Triosephosphate isomerase, LC-COPD | TPIS_HUMAN | 26.7 | 418 |
Proteasome activator complex subunit 1, LC-COPD | PSME1_HUMAN | 28.7 | 165 |
Thymidine phosphorylase, LC-COPD | TYPH_HUMAN | 50.3 | 80 |
26S protease regulatory subunit 6A, LC-COPD | PRS6A_HUMAN | 49.20 | 642 |
60 kDa heat shock protein, mitochondrial, LC-COPD | CH60_HUMAN | 61.2 | 80 |
Actin, cytoplasmic 1, LC-COPD | ACTB_HUMAN | 41.7 | 90 |
5′-AMP-activated protein kinase subunit γ-2, LC-COPD | AAKG2_HUMAN | 63.2 | 63 |
Cofilin-1, LC | COF1_HUMAN | 18.5 | 57 |
Transthyretin, LC | tthy_human | 15.9 | 405 |
Ferritin light chain, LC | FRIL_HUMAN | 20.06 | 92 |
Nontumor lung specimens | |||
Protein DJ-1, LC-COPD and LC | PARK7_HUMAN | 19.9 | 309 |
Transthyretin, LC-COPD and LC | tthy_human | 15.9 | 68 |
Vimentin, LC-COPD and LC | VIME_HUMAN | 53.6 | 172 |
Actin, cytoplasmic, LC-COPD and LC | ACTB_HUMAN | 41.7 | 160 |
Serotransferrin, LC-COPD and LC | TRFE_HUMAN | 79.29 | 169 |
Triosephosphate isomerase, LC-COPD and LC | TPIS_HUMAN | 26.7 | 82 |
Serum amyloid P-component, LC-COPD and LC | SAMP_HUMAN | 25.5 | 123 |
Glutathione S-transferase, LC-COPD and LC | GSTP1_HUMAN | 23.6 | 80 |
ATP synthase subunit beta, LC-COPD and LC | ATPB_HUMAN | 56.5 | 118 |
Carbonic anhydrase 1, LC-COPD and LC | CAH1_HUMAN | 28.9 | 57 |
Apolipoprotein A-I, LC-COPD and LC | APOA1_HUMAN | 30.8 | 83 |
Actin, cytoplasmic 1, LC-COPD and LC | ACTB_HUMAN | 41.7 | 59 |
Hemoglobin subunit beta, LC-COPD and LC | HBB_HUMAN | 16.0 | 62 |